Entheon Biomedical

Press

Entheon Biomedical Announces DMT Drug Supply Agreement with Psygen Labs Inc. Completion of Initial DMT Research Drug Batch

Quick Take: Entheon Biomedical Corp. announced it has entered into a drug-supply agreement with Psygen Labs Inc. The agreement provides Entheon with DMT drug material for preliminary formulation, stability and testing required prior to its forthcoming human clinical trial, scheduled to begin in Q4 2021 Entheon shareholders have also exercised an aggregate 533,359 warrants at […]

Entheon Biomedical

Press

Entheon Biomedical to Begin Trading on the Frankfurt Exchange

Quick Take: Entheon Biomedical Corp. shares have commenced trading on the Frankfurt Stock Exchange under the symbol “1XU1” The Company’s shares will also continue to trade on the Canadian Securities Exchange under the symbol “ENBI“. Vancouver, British Columbia–(Newsfile Corp. – November 26, 2020) – Entheon Biomedical Corp. (CSE: ENBI) (FSE: 1XU1) (“Entheon” or the “Company”), a […]